Browse the corpus

Intense pulsed light (IPL) therapy was first developed in 1992 to treat leg telangiectasias. Its effectiveness was initially demonstrated in studies on rabbit ear veins, showcasing its ability to thermocoagulate vessels with minimized purpura and epidermal damage. This activity provides an in-depth review of the physics underlying IPL therapy, covering its indications, contraindications, and technical aspects of delivery. It emphasizes the pivotal role of the interprofessional healthcare team in administering IPL treatments, fostering a comprehensive understanding of this versatile technology's applications. Since the FDA's approval of the first IPL device in 1995, continuous innovation has expanded its clinical applications, making it a safe and effective option for various pigmented and vascular disorders, hair removal, and addressing signs of photoaging. IPL devices stand out for their use of flashlamps and bandpass filters, enabling the generation of pulsed light with varying wavelengths, durations, and fluences. This versatility makes IPL an invaluable tool in dermatology, effectively treating conditions such as melasma, lentigines, telangiectasias, and rosacea. This activity underscores the significant advancements in IPL technology and its increasing affordability, highlighting its present status as a widely utilized modality in addressing both functional and cosmetic dermatological concerns. Learners will gain a comprehensive understanding of IPL therapy, empowering them to integrate this technology effectively into their clinical practice for enhanced patient outcomes. Objectives: Differentiate between the specific dermatologic conditions for which intense pulsed light therapy and laser energy are optimal, considering factors such as pigmentation and vascularity. Identify dermatologic conditions appropriate for intense pulsed light therapy, considering factors such as pigmentation and vascularity. Implement standardized safety protocols for intense pulsed light therapy in order to avoid post-treatment complications. Collaborate with members of the interprofessional team to ensure a clear understanding of intense pulsed light therapy indications, patient concerns, and posttreatment care plans. Access free multiple choice questions on this topic.

Intense pulsed light (IPL) therapy was first developed in 1992 by Doctors Goldman, Fitzpatrick, and Eckhouse for the treatment of leg telangiectasias. Proof-of-concept studies were conducted on rabbit ear veins, demonstrating IPL's ability to thermocoagulate vessels while minimizing purpura and epidermal damage.[1] Since the first United States Food and Drug Administration (FDA)-approved IPL device was brought to the market in 1995, this technology has undergone significant innovation and improvement in its clinical applications and affordability.[2][3] IPL devices are unique in that they employ flashlamps and bandpass filters to produce pulsed light of varying wavelengths, durations, and fluences. These characteristics provide IPL versatility in addressing numerous dermatological conditions.[4][5] IPL is safe and effective in treating benign pigmented and vascular disorders as well as performing hair removal and reducing signs of photoaging.[6] Currently, IPL is an invaluable tool in dermatology and is frequently used to address a broad range of functional and cosmetic concerns.[7]

Although side effects of IPL are typically rare and minimal in severity, the most common adverse events include pain and erythema. Other reported side effects include edema, bullae, hematoma, crusting, hyper-  or hypopigmentation, leukotrichia, scarring, keloid formation, and infection.[21] For untrained medical providers, the use of inappropriate device settings and administration of excess energy can lead to nonspecific thermal damage and complications. IPL is particularly challenging to use on dark-skinned individuals, and careful consideration must be given to these patients. Shorter wavelengths are generally reserved for fair skin types, as these wavelengths are absorbed by melanin and lead to pigmentation changes in patients with darker skin. However, device-related cooling technology has helped minimize these side effects in patients with darker complexions. Skin reactions typically last for about 2 to 48 hours after treatment and often depend on the fluence, pulse duration, and specific treatment area. Higher fluences and pulse durations, thinner skin, and darker skin types may increase the likelihood of adverse events. In patients undergoing hair removal, the adverse effect of paradoxical hypertrichosis may occur.[22] This is the phenomenon of the growth of fine, dark hair in areas close to the target tissue, especially in patients with darker skin types (Fitzpatrick III-VI). The underlying mechanism has not been fully elucidated. Still, potential causes include IPL stimulating hair follicular stem cells to promote hair growth and inducing the release of cytokines and growth factors with the conversion of vellus hairs to terminal hairs.[23][24] Treatment options include increasing the energy, decreasing the interval between treatments, using more cooling, changing the wavelengths (eg, from IPL to 1,064-nm Nd:YAG laser), and using topical eflornithine to slow down hair regrowth after treatments.

Achieving the best outcomes with intense pulsed light therapy involves an interprofessional team of healthcare providers, including a skilled dermatologist or plastic surgeon and often a physician assistant or nurse practitioner, aesthetician, medical assistant, and office staff. The patient should be educated on what to expect during and after the procedure as well as potential side effects. For example, the patient should be counseled on cold gel application before IPL delivery and using protective eyewear during sessions as well as the importance of sun protection after treatment. It is also important to gauge the patient's expectations and assess clinical improvement accordingly. Patients should be informed that the best results are achieved after a series of at least 2 or more IPL treatments.